Download Supplement
Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial DesignByPeter K. Kaiser, MD,Jeffrey Heier, MD,Nadia K. Waheed, MD, MPHJuly 28th 2025
Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?July 17th 2025
Real World insights with EYLEA 8mgByDr Peter Kaiser, Cole Eye Institute, Cleveland Clinic, USAJuly 14th 2025
EYLEA 8mg in focus: Key learnings from the pivotal trialsByProfessor Varun Chaudhary, McMaster University, CanadaJune 5th 2025